IL ‐37 possesses both anti‐inflammatory and antiviral effects against Middle East respiratory syndrome coronavirus infection
Animal Models and Experimental Medicine · 2025
DOI: 10.1002/ame2.12435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Feifei Qi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases, NHC Key Laboratory of Comparative Medicine, Institute of Lab…. Hauptthemen laut MEDLINE: Interleukin-1, Middle East Respiratory Syndrome Coronavirus, Antiviral Agents, Anti-Inflammatory Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China, the CAMS initiative for Innovative Medicine of China, Young Elite Scientists Sponsorship Program by CAST (YESS).
Abstract (Originalsprache)
Background
The aim was to elucidate the function of IL‐37 in middle east respiratory syndrome coronavirus (MERS‐CoV) infection, thereby providing a novel therapeutic strategy for managing the clinical treatment of inflammatory response caused by respiratory virus infection.
Methods
We investigated the development of MERS by infecting hDPP4 mice with hCoV‐EMC (10 7 TCID 50 [50% tissue culture infectious dose]) intranasally. We infected A549 cells with MERS‐CoV, which concurrently interfered with IL‐37, detecting the viral titer, viral load, and cytokine expression at certain points postinfection. Meanwhile, we administered IL‐37 (12.5 μg/kg) intravenously to hDPP4 mice 2 h after MERS‐CoV‐2 infection and collected the serum and lungs 5 days after infection to investigate the efficacy of IL‐37 in MERS‐CoV infection.
Results
The viral titer of MERS‐CoV‐infected A549 cells interfering with IL‐37 was significantly reduced by 4.7‐fold, and the viral load of MERS‐CoV‐infected hDPP4 mice was decreased by 59‐fold in lung tissue. Furthermore, the administration of IL‐37 suppressed inflammatory cytokine and chemokine (monocyte chemoattractant protein 1, interferon‐γ, and IL‐17A) expression and ameliorated the infiltration of inflammatory cells in hDPP4 mice.
Conclusion
IL‐37 exhibits protective properties in severe pneumonia induced by MERS‐CoV infection. This effect is achieved through attenuation of lung viral load, suppression of inflammatory cytokine secretion, reduction in inflammatory cell infiltration, and mitigation of pulmonary injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases, NHC Key Laboratory of Comparative Medicine, Institute of Laboratory Animal Science, CAMS & PUMC, Beijing, China.
- National Center of Technology Innovation for Animal Model, Beijing, China.
- State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, China.
ORCID-Profile: Qi Lv, Linlin Bao
Förderung
- the National Natural Science Foundation of China
- the CAMS initiative for Innovative Medicine of China
- Young Elite Scientists Sponsorship Program by CAST (YESS)
Zitieren
APA
Qi, F., Yan, Y., Lv, Q., Liu, M., Liu, M., Li, F., Deng, R., Liang, X., Li, S., Mou, G., & Bao, L. (2025). IL ‐37 possesses both anti‐inflammatory and antiviral effects against Middle East respiratory syndrome coronavirus infection. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12435
Vancouver
Qi F, Yan Y, Lv Q, Liu M, Liu M, Li F, et al. IL ‐37 possesses both anti‐inflammatory and antiviral effects against Middle East respiratory syndrome coronavirus infection. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.12435
BibTeX
@article{Qi2025,
author = {Qi, Feifei and Yan, Yiwei and Lv, Qi and Liu, Mingya and Liu, Ming and Li, Fengdi and Deng, Ran and Liang, Xujian and Li, Shuyue and Mou, Guocui and Bao, Linlin},
title = {IL ‐37 possesses both anti‐inflammatory and antiviral effects against Middle East respiratory syndrome coronavirus infection},
journal = {Animal Models and Experimental Medicine},
year = {2025},
doi = {10.1002/ame2.12435}
}
EUVIMED